CARDINAL HEALTH INC (CAH)

US14149Y1082 - Common Stock

123.42  +3.08 (+2.56%)

After market: 123.42 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
181.364B
11.63%		205.012B
13.04%		226.827B
10.64%		220.983B
-2.58%
EBITDA
YoY % growth
2.369B
-8.88%		2.466B
4.09%		2.86B
15.98%		3.096B
8.25%
EBIT
YoY % growth
1.677B
-7.71%		1.774B
5.78%		2.15B
21.20%		2.493B
15.95%
Operating Margin
0.92%0.87%0.95%1.13%
EPS
YoY % growth
5.06
-16.78%		5.81
14.82%		7.47
28.57%		7.86
5.19%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		1.77
-2.84%
Revenue
Q2Q % growth		54.564B
-5.02%
EBITDA
Q2Q % growth		720.8M
-14.90%
EBIT
Q2Q % growth		593.15M
18.63%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 1.88
8.67%		1.630.2515.13%
Q4 2024
Q2Q % growth		 1.84
18.71%		1.760.084.62%
Q3 2024
Q2Q % growth		 2.08
19.54%		1.970.115.55%
Q2 2024
Q2Q % growth		 1.82
37.88%		1.620.2012.64%
Q1 2024
Q2Q % growth
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 52.277B
-4.54%		51.404B873M1.70%
Q4 2024
Q2Q % growth		 59.867B
12.00%		59.285B582M0.98%
Q3 2024
Q2Q % growth		 54.911B
8.76%		56.615B-1.704B-3.01%
Q2 2024
Q2Q % growth		 57.445B
11.61%		57.583B-138M-0.24%
Q1 2024
Q2Q % growth
Q4 2023
Q2Q % growth
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.81% -1.81% 1.99% 3.27%
Revenue1.15% 1.15% 1.04% 4.3%